Pivotal advance: Vasoactive intestinal peptide inhibits up-regulation of human monocyte TLR2 and TLR4 by LPS and differentiation of monocytes to macrophages

Journal of Leukocyte Biology

Volumn 81, Issue 4, 2007, Pages 893-903

  Foster, N ^a   Lea, S R ^a   Preshaw, P M ^a   Taylor, J J ^a  

^a NEWCASTLE UNIVERSITY   (United Kingdom)

Author keywords

Lipopolysaccharide; Myeloid cells; Toll like receptors; VIP

Indexed keywords

LIPOPOLYSACCHARIDE; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 4; TRANSCRIPTION FACTOR PU 1; VASOACTIVE INTESTINAL POLYPEPTIDE;

ARTICLE; CELL DIFFERENTIATION; CELL STIMULATION; CYTOKINE RELEASE; ESCHERICHIA COLI; HUMAN; HUMAN CELL; IMMUNOMODULATION; MACROPHAGE; MONOCYTE; PERIODONTICS; PORPHYROMONAS GINGIVALIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN INDUCTION; PROTEIN TRANSPORT; UPREGULATION;

CELL DIFFERENTIATION; CELL NUCLEUS; CELLS, CULTURED; DRUG INTERACTIONS; HUMANS; IMMUNOSUPPRESSIVE AGENTS; LIPOPOLYSACCHARIDES; MACROPHAGES; MONOCYTES; PROTEIN TRANSPORT; PROTO-ONCOGENE PROTEINS; TOLL-LIKE RECEPTOR 2; TOLL-LIKE RECEPTOR 4; TRANS-ACTIVATORS; UP-REGULATION; VASOACTIVE INTESTINAL PEPTIDE;

ANIMALIA; ESCHERICHIA COLI; PORPHYROMONAS GINGIVALIS;

EID: 33947643643     PISSN: 07415400     EISSN: None     Source Type: Journal    
DOI: 10.1189/jlb.0206086     Document Type: Article

References (37)

1. Delgado, M., Pozo, D., Ganea, D. (2004) The significance of vasoactive intestinal peptide. Pharmacol. Rev. 56, 249-290.
2. Kirschning, C. J., Wesche, H., Merrill Ayres, T., Rothe, M. (1998) Human Toll-like receptor 2 confers responsiveness to bacterial lipopolysaccharide. J. Exp. Med. 188, 2091-2097.
3. Chow, J. C., Young, D. W., Golenbock, D. T., Christ, W. J., Gusovsky, F. (1999) Toll-like receptor-4 mediates lipopolysaccharide-induced signal transduction. J. Biol. Chem. 274, 10689-10692.
4. Tapping, R. I., Akashi, S., Miyake, K., Godowski, P. J., Tobias, P. S. (2000) Toll-like receptor 4, but not Toll-like receptor 2, is a signaling receptor for Escherichia and Salmonella lipopolysaccharides. J. Immunol. 165, 5780-5787.
5. Darveau, R. P., Pham, T. T., Lemley, K., Reife, R. A., Bainbridge, B. W., Coats, S. R., Howald, W. N., Way, S. S., Hajjar, A. M. (2004) Porphyromonas gingivalis lipopolysaccharide contains multiple lipid A species that functionally interact with both Toll-like receptors 2 and 4. Infect. Immun. 72, 5041-5051.
6. Gutiérrez-Cañas, I., Juarranz, Y., Santiago, B., Arranz, A., Martinez, C., Galindo, M., Payá, M., Gomariz, R. P., Pablos, J. L. (2006) VIP downregulates TLR4 expression and TLR4-mediated chemokine production in human rheumatoid synovial fibroblasts. Rheumatology 45, 527-532.
7. Gomariz, R. P., Arranz, A., Abad, C., Torroba, M., Martinez, C., Rosignoli, F., Garcia-Gómez, M., Leceta, J., Juarranz, Y. (2005) Time-course expression of Toll- like receptors 2 and 4 in inflammatory bowel disease and homeostatic effect of VIP. J. Leukoc. Biol. 78, 491-502.
8. Abad, C., Juarranz, Y., Martinez, C., Arranz, A., Rosignoli, F., Garcia-Gómez, M., Leceta, J., Gomariz, R. P. (2005) cDNA array analysis of cytokines, chemokines, and receptors involved in the development of TNBS-induced colitis: homeostatic role of VIP. Inflamm. Bowel Dis.11, 674-684.
9. Delgado, M., Ganea, D. (2001) Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide inhibit nuclear factor-κB- dependent gene activation at multiple levels in the human monocytic cell line THP-1. J. Biol. Chem. 276, 369-380.
10. Musikacharoen, T., Matsuguchi, T., Kikuchi, T., Yoshikai, Y. (2001) NF-κ and STAT5 play important roles in the regulation of mouse Toll-like receptor 2 gene expression. J. Immunol. 166, 4516-4524.
11. Rehli, M. (2002) Of mice and men: species variation of Toll-like receptor variation. Trends Immunol. 23, 375-378.
12. Haehnel, V., Schwarzfischer, L., Fenton, M. J., Rehli, M. (2002) Transcriptional regulation of the human Toll-like receptor 2 gene in monocytes and macrophages. J. Immunol. 168, 5629-5637.
13. Rehli, M., Poltorak, A., Schwarzfischer, L., Krause, S. W., Andreesen, R., Beutler, B. (2000) PU.1 and interferon consensus sequence-binding protein regulate the myeloid expression of the human Toll-like receptor 4 gene. J. Biol. Chem. 275, 9773-9781.
14. Lamont, R. J., Jenkinson, H. F. (1998) Life below the gum line: pathogenic mechanisms of Porphyromonas gingivalis. Microbiol. Mol. Biol. Rev. 62, 1244-1263.
15. Linden, G. J., Mullally, B. H., Burden, D. J., Lamey, P. J., Shaw, C., Ardill, J., Lundy, F. T. (2002) Changes in vasoactive intestinal peptide in gingival crevicular fluid in response to periodontal treatment. J. Clin. Periodontol. 29, 484-489.
16. Foster, N., Cheetham, J., Taylor, J. J., Preshaw, P. M. (2005) VIP inhibits Porphyromonas gingivalis LPS-induced immune responses in human monocytes J. Dent. Res. 84, 999-1004.
17. Kitchens, R. L., Ulevitch, R. J., Munford, R. S. (1992) Lipopolysaccharide (LPS) partial structures inhibit responses to LPS in a human macrophage cell line without inhibiting LPS uptake by a CD14-mediated pathway. J. Exp. Med. 176, 485-494.
18. Buras, J. A., Reenstra, W. R., Fenton, M. J. (1995) NF β A, a factor required for maximal interleukin-1 β gene expression, is identical to the ets family member PU.1. Evidence for structural alteration following LPS activation. Mol. Immunol. 32, 541-554.
19. Ganea, D., Delgado, M. (2002) Vasoactive intestinal peptide (VIP) and pituitary adenylate cyclase-activating polypeptide (PACAP) as modulators of both innate and adaptive immunity. Crit. Rev. Oral Biol. Med. 13, 229-237.
20. Ganea, D., Rodriguez, R., Delgado, M. (2003) Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide: players in innate and adaptive immunity. Cell. Mol. Biol. 49, 127-142.
21. Delgado, M., Ganea, D. (2003) Vasoactive intestinal peptide inhibits IL-8 production in human monocytes. Biochem. Biophys. Res. Commun. 301, 825-832.
22. Totemeyer, S., Foster, N., Kaiser, P., Maskell, D. J., Bryant, C. E. (2003) Toll-like receptor expression in C3H/HeN and C3H/HeJ mice during Salmonella enterica serovar Typhimurium infection. Infect. Immun. 71, 6653-6657.
23. Muthukuru, M., Jotwani, R., Cutler, C. W. (2005) Oral mucosal endotoxin tolerance induction in chronic periodontitis. Infect. Immun. 73, 687-694.
24. Hajishengallis, G., Martin, M., Schifferle, R. E., Genco, R. J. (2002) Counteracting interactions between lipopolysaccharide molecules with differential activation of Toll-like receptors. Infect. Immun. 70, 6658-6664.
25. Yanagitani, Y., Rakugi, H., Okamura, A., Moriguchi, K., Takiuchi, S., Ohishi, M., Suzuki, K., Higaki, J., Ogihara, T. (1999) Angiotensin II type receptor-mediated peroxide production in human macrophages. Hypertension 33, 335-339.
26. Baqui, A. A., Meiller, T. F., Kelley, J. I., Turng, B. F., Falkler, W. A. (1999) Antigen activation of THP-1 human monocytic cells after stimulation with lipopolysaccharide from oral microorganisms and granulocyte-macrophage colony-stimulating factor. J. Periodontal Res. 34, 203-213.
27. Liew, F. Y., Xu, D., Brint, E. K., O'Neill, L. A. (2005) Negative regulation of Toll-like receptor-mediated immune responses. Nat. Rev. Immunol. 5, 446-458.
28. LeBouder, E., Rey-Nores, J. E., Rushmere, N. K., Grigorov, M., Law, S. D., Michael, A., Griffin, G. E., Ferrara, P., Schiffrin, E. J., Morgan, B. P., Labéta, M. O. (2003) Soluble forms of Toll-like receptor (TLR)2 capable of modulating TLR2 signaling are present in human plasma and breast milk. J. Immunol. 171, 6680-6689.
29. Iwami, K-I., Matsuguchi, T., Masuda, A., Kikuchi, T., Musikacharoen, T., Yoshikai, Y. (2000) Cutting edge: naturally occurring soluble form of mouse Toll-like receptor 4 inhibits lipopolysaccharide signaling. J. Immunol. 165, 6682-6686.
30. Chuang, T. H., Ulevitch, R. J. (2004) Triad3A, an E3 ubiquitin-protein ligase regulating Toll-like receptors. Nat. Immunol. 5, 495-502.
31. Delgado, M., Ganea, D. (1999) Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide inhibit interleukin-12 transcription by regulating nuclear factor κB and Ets activation. J. Biol. Chem. 274, 31930-31940.
32. Shivdasani, R. A., Orkin, S. H. (1996) The transcriptional control of hematopoiesis. Blood 87, 4025-4039.
33. Zhang, D. E., Hetherington, C. J., Chen, H. M., Tenen, D. G. (1994) The macrophage transcription factor PU.1 directs tissue-specific expression of the macrophage colony-stimulating factor receptor. Mol. Cell. Biol. 14, 373-381.
34. Anderson, K. L., Smith, K. A., Conners, K., McKercher, S. R., Maki, R. A., Torbett, B. E. (1998) Myeloid development is selectively disrupted in PU.1 null mice. Blood 91, 3702-3710.
35. Bohmann, D., Bos, T. J., Admon, A., Nishimura, T., Vogt, P. K., Tjian, R. (1987) Human proto-oncogene c-jun encodes a DNA binding protein with structural and functional properties of transcription factor AP-1. Science 238, 1386-1392.
36. Behre, G., Whitmarsh, A. J., Coghlan, M. P., Hoang, T., Carpenter, C. L., Zhang, D. E., Davis, R. J., Tenen, D. G. (1999) c-Jun is a JNK-independent coactivator of the PU.1 transcription factor. J. Biol. Chem. 274, 4939-4946.
37. Caron, G., Duluc, D., Fremaux, I., Jeannin, P., David, C., Gascan, H., Delneste, Y. (2005) Direct stimulation of human T cells via TLR5 and TLR7/8: flagellin and R-848 up-regulate proliferation and IFN-γ production by memory CD4+ T cells. J. Immunol. 175, 1551-1557.